-
June 17, 2013
Ironwood Pharmaceuticals announced that it has launched Constella in Europe
-
January 17, 2013
Forest Labs' miss doesn't seem like a thesis-changing event.
-
January 16, 2013
Ironwood Pharmaceuticals, Inc.'s (IRWD) fourth-quarter 2012 loss of 41 cents per share compared unfavorably with the ...
-
January 09, 2013
Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The company continues to ...
-
January 09, 2013
Forest Laboratories, Inc. (FRX) recently entered into a settlement agreement with Glenmark Pharmaceuticals Ltd., ...
-
January 09, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently provided an update on its performance in 2012 and its plans for 2013. ...
-
January 08, 2013
Cubist Pharmaceuticals Inc.'s (CBST) unaudited net revenues for the fourth quarter of 2012 climbed 16% year over ...
-
January 07, 2013
Entrepreneurial pharmaceutical company, Ironwood Pharmaceuticals, Inc. (IRWD) recently announced that it has ...
-
January 07, 2013
Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. (IPXL), a specialty pharmaceutical company, ...
-
January 07, 2013
Salix Pharmaceuticals, Ltd. (SLXP) recently said that the FDA has approved the company's anti-diarrhea drug for ...
-
January 07, 2013
Watson Pharmaceuticals, Inc. (WPI) recently announced that it gained US Food and Drug Administration (FDA) approval ...
-
January 07, 2013
Valeant Pharmaceuticals International Inc. (VRX) recently provided its guidance for 2013. Valeant expects to ...
-
January 07, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) and Xstelos Holdings, Inc. (XTLS) recently received a notice from Upsher-Smith ...
-
January 03, 2013
Synergy Pharmaceuticals (SGYP) recently presented positive results from a phase IIb/III study on its chronic ...
-
January 03, 2013
On January 2, 2013, Zacks Investment Research upgraded Ironwood Pharmaceuticals, Inc.'s (IRWD) to a Zacks #1 Rank ...
-
December 31, 2012
Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients ...
-
December 31, 2012
Forest Labs (FRX) and Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited ...
-
December 27, 2012
Ironwood Pharmaceuticals Inc. (IRWD) recently commenced a phase I study in the US with its anti-anxiety candidate, ...
-
December 24, 2012
Cubist Pharmaceuticals Inc. (CBST) announced that it has filed for the approval of its drug Entereg (alvimopan) for ...
-
December 19, 2012
Forest Laboratories, Inc. (FRX) and partner Ironwood Pharmaceuticals, Inc. (IRWD) recently launched Linzess ...
